Global Biotech Corp.'s Transition From Development Phase to Production Phase
September 15 2011 - 3:00PM
Global Biotech Corp. (OTCBB:GBIQ) is a publicly traded company with
interests in the retail phyto-chemical, nutraceutical,
cosmeceutical and pharmaceutical areas. Global owns the trademarked
product AquaBoost (TM), an oxygenated spring water.
www.globalbiotechcorp.com.
Global Biotech Corp. as of September 14, 2011 has made the
transition from OTCQB to OTCBB. The company is current in its
filings and a full reporting company with the Securities Exchange
Commission.
Global Biotech announces that the development phase of our
AquaBoost process is completed and the company is moving into the
production phase. We are currently installing AquaBoost at a Quebec
bottling plant and will be bringing the first wave to market in
October. For more information, please visit www.aquaboost.com.
"This transition will take Global Biotech Corp. from an "in
development" company to a producing entity with a viable health
product ready for sale. We are pleased to be able to announce to
the public that Global Biotech Corp. will manufacture and market
the AquaBoost product to select Canadian and U.S. customers," said
Louis Greco, Global's Chief Executive Officer.
About: Global Biotech Corp. is dedicated to investigating and
developing Green technology platforms to
conserve our natural resources by curbing the negative impacts
of human involvement. Global is positioning its AquaBoost
(TM) product as a top quality oxygenated water due to its
unique oxygenation level (up to 100 ppm and greater), allowing the
body to retain a higher level of oxygenation over lengthy periods
of time. The company guarantees the purity of this product. The
Company is also in the process of developing other
naturally oxygenated beverages and fruit juices.
Forward-Looking Statements
This press release may contain forward-looking statements that
involve risks and uncertainties, which may include statements about
business strategy and development plans, plans for entering into
new business, anticipated sources of funds, including the proceeds
from future operations, and plans, objectives, expectations and
intentions contained in this Press Release that are not historical
facts. When used in this Press Release, the words "expects,"
"intends," "projects," "plans," "believes," "seeks," "estimates"
and similar expressions are generally intended to identify
forward-looking statements. Because these forward-looking
statements involve risk and uncertainties, actual results could
differ materially from those discussed in this Press Release. These
risks are outlined in our SEC filings.
CONTACT: Louis Greco, CEO Global Biotech Corp
Tel: (302) 288 0658
info@globalbiotechcorp.com